These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 144660)

  • 1. [Improved scintigraphic imaging of the adrenals with 6beta-131I-iodomethyl-cholesterol (author's transl)].
    Tragl KH; Angelberger P; Pils P; Wiesinger F; Kletter K
    Rofo; 1977 Oct; 127(4):365-9. PubMed ID: 144660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenal scanning and uptake with 131I-6beta-iodomethyl-nor-cholesterol.
    Ryo UY; Johnston AS; Kim I; Pinsky SM
    Radiology; 1978 Jul; 128(1):157-61. PubMed ID: 663202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of 19-iodocholesterol-131I with 6beta-iodomethyl-19-norcholest-5(10)-en-3beta-ol-131I as an adrenal-scanning agent.
    Nitta K; Ogawa H; Ito T; Kojima M; Maeda M
    Chem Pharm Bull (Tokyo); 1976 Oct; 24(10):2322-6. PubMed ID: 1017078
    [No Abstract]   [Full Text] [Related]  

  • 4. A new and superior adrenal imaging agent, 131I-6beta-iodomethyl-19-nor-cholesterol (NP-59): evaluation in humans.
    Sarkar SD; Cohen EL; Beierwaltes WH; Ice RD; Cooper R; Gold EN
    J Clin Endocrinol Metab; 1977 Aug; 45(2):353-62. PubMed ID: 885997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Adrenal scintigraphy with 131I-6beta-iodomethyl-19-norcholesterol: good practice guideline].
    Bardet S; Nocaudie-Calzada M; Kraimps JL; Tabarin A; Wémeau JL
    Ann Endocrinol (Paris); 1998 Nov; 59(4):344-53. PubMed ID: 9864556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of pharmacological preparations for the purpose of improving the visualization of the adrenals with 19-iodocholesterol-131I].
    Slavnov VN; Valueva GV; Markov VV; Luchitskiĭ EV; Iakovlev AA
    Med Radiol (Mosk); 1979 Jan; 24(1):37-41. PubMed ID: 215865
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of specific radioactivities and cholagogues on tissue distribution of 131I-6 beta-iodomethyl-19-norcholest-5(10)-en-3 beta-ol(NCL-6-131I) in rats].
    Ito T; Ogawa H; Maeda M; Kojima M
    Yakugaku Zasshi; 1983 Jun; 103(6):644-9. PubMed ID: 6655551
    [No Abstract]   [Full Text] [Related]  

  • 8. A new and superior adrenal scanning agent, NP-59.
    Sarkar SD; Beierwaltes H; Ice RD; Basmadjian GP; Hetzel KR; Kennedy WP; Mason MM
    J Nucl Med; 1975 Nov; 16(11):1038-42. PubMed ID: 1185265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Scintigraphy of the adrenal glands].
    Tragl KH; Kletter K
    Acta Med Austriaca; 1978; 5(4-5):150-2. PubMed ID: 756128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical and radiochemical stability of the adrenal-scanning agents, 6beta-iodomethyl-19-norcholest-5(10-en-3beta-ol and 19-iodocholest-5-en-3beta-ol.
    Scott KN; Mareci TH; Couch MW; Williams CM
    Steroids; 1977 Oct; 30(4):511-9. PubMed ID: 605458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenal scintigraphy in primary aldosteronism. Improved visualization after long-term pre-treatment with dexamethasone.
    Hoefnagels WH; Claessens RA; Corstens FH; Drayer JI; Kazem I; Kloppenborg PW
    Nuklearmedizin; 1981 Apr; 20(2):76-81. PubMed ID: 7243603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High thyroid radiation dose associated with 131-I-19-iodocholesterol adrenal scanning.
    O'Connor MK; Cullen MJ; Malone JF
    Br J Radiol; 1979 Feb; 52(614):130-3. PubMed ID: 427363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical study of adrenal imaging with 123I-labeled-6 beta-iodomethyl-19-norcholesterol (author's transl)].
    Shishido F; Tateno Y; Ido T; Irie T; Suzuki K; Fukushi K; Iwata R; Kojima M; Maeda M; Ito T; Ogawa H
    Radioisotopes; 1980 Nov; 29(11):526-32. PubMed ID: 7244299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of a new adrenal scanning agent, 6-methyl-75Se-selenomethyl-19-norcholest-5 (10)-en-3 beta-ol (75Se-Scintadren) and 6 beta-iodomethyl-19-norcholest-5 (10)-en-3 beta-ol (131I-Adosterol) (author's transl)].
    Seto H; Futatsuya R; Mori H; Koizumi K; Hisada K
    Kaku Igaku; 1979 Apr; 16(2):183-9. PubMed ID: 470240
    [No Abstract]   [Full Text] [Related]  

  • 15. [Scintigraphy of the adrenals using 19-iodocholesterol-131I].
    Zubovskiĭ GA; Turaev RN; Marova EI
    Med Radiol (Mosk); 1978 Jan; 23(1):45-9. PubMed ID: 342859
    [No Abstract]   [Full Text] [Related]  

  • 16. Uptake of 131I-19-cholesterol by normal and spontaneously hyperfunctioning canine adrenals.
    van den Brom WE; Rijnberk A; Lubberink AA; de Bruijne JJ
    Eur J Nucl Med; 1979 Feb; 4(1):61-67. PubMed ID: 227690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical values of adrenal scintigraphy by I-6-beta-iodomethyl-19-norcholesterol (123I-NCL) (author's transl)].
    Tateno Y; Shishido F; Kamoi I; Matsuura K; Takagi Y; Hashimoto S; Hotta T; Arimizu N; Fukushi K; Irie T; Ido T; Kojima M; Maeda M; Ogawa H; Itoh T
    Kaku Igaku; 1982 Mar; 19(2):245-53. PubMed ID: 7109324
    [No Abstract]   [Full Text] [Related]  

  • 18. Radioisotopic study of the adrenal glands using 131I-19-iodocholesterol.
    Troncone L; Galli G; Salvo D; Barbarino A; Bonomo L
    Br J Radiol; 1977 May; 50(593):340-9. PubMed ID: 861453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative study of adrenal gland scanning agents, 6beta-iodomethyl-19-nor-cholest-5(10)-en-3beta-o1-131I (NCL-6-131I) and 131I-19-cholesterol (CL-19-131I)].
    Fukuchi S; Nakajima K; Miura T; Haruyama K; Kida T
    Kaku Igaku; 1976 Dec; 13(6):775-9. PubMed ID: 1035359
    [No Abstract]   [Full Text] [Related]  

  • 20. Irradiation therapy with 131I-6beta-iodocholesterol of metapyralone induced adrenal hyperplasia in rats.
    Tragl KH; Kinast H; Hinterberger H; Angelberger P; Kletter K
    Res Exp Med (Berl); 1978 Mar; 172(2):137-41. PubMed ID: 644137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.